Skip to content

Dobbhoff Polypectomy Snare

by Biosearch Medical Products, Inc.

510(k) K901322

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK901322 Date15 Jun 1990ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Dobbhoff(R) Polypectomy Snare
510(k) Number
FDA Product Code
FDI
Device Class
Class II
Regulation
21 CFR Part 876.4300
Advisory Committee
Gastroenterology, Urology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Dobbhoff Polypectomy Snare is a flexible snare device designed for endoscopic polypectomy. It is classified as a Snare, Flexible under FDA regulation 876.4300, intended for use in the removal of polyps during gastrointestinal procedures. Its construction allows for precise manipulation within the colon or upper gastrointestinal tract, facilitating safe and effective excision of benign or malignant growths.

This device is supplied as a single-use, non-sterile instrument and is regulated under FDA 510(k) clearance (K901322) with a Substantially Equivalent determination. It is intended for use in Gastroenterology and Urology settings, adhering to traditional review standards. Multiple reference codes (e.g., FDI) and FEI numbers identify its regulatory classification, ensuring compliance with medical device standards for endoscopic procedures.

Other devices from Biosearch Medical Products, Inc.

See all devices from Biosearch Medical Products, Inc. →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Is the Dobbhoff Polypectomy Snare intended for use in both colon and upper gastrointestinal procedures, and how does its design support this flexibility?

    Yes, the Dobbhoff Polypectomy Snare is designed for use in both the colon and upper gastrointestinal tract. Its flexible construction allows for precise manipulation within these areas, enabling safe and effective excision of polyps during endoscopic procedures. The snare’s adaptability is key to navigating the varying anatomies of these regions.

  • What is the intended use of the Dobbhoff Polypectomy Snare, and which medical specialties commonly utilize this device?

    The Dobbhoff Polypectomy Snare is intended for the removal of polyps—both benign and malignant—during endoscopic procedures. It is primarily used in Gastroenterology and Urology settings, where precise polypectomy is required. The device’s classification under FDA regulation 876.4300 (Snare, Flexible) reflects its role in these specialties.

  • Is the Dobbhoff Polypectomy Snare sterile when supplied, and how should it be handled before use?

    The Dobbhoff Polypectomy Snare is supplied as a single-use, non-sterile instrument. Before use, it must be sterilized according to standard medical protocols to ensure patient safety. Always follow facility-specific guidelines for sterilization and preparation.

  • What regulatory pathway was followed for the FDA clearance of the Dobbhoff Polypectomy Snare, and what does the 'Substantially Equivalent' determination mean?

    The Dobbhoff Polypectomy Snare received FDA clearance via a 510(k) submission (K901322) under the Traditional Review pathway, with a Substantially Equivalent (SESE) determination. This means the device was found to be as safe and effective as a legally marketed predicate device already on the market, meeting FDA standards for flexible snares used in polypectomy.